Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

Abstract

This is an investigator initiated trial to assess the efficacy and safety of a GPC3-targeting CAR-T therapy (REVO-UWD-03) in the HCC and Lung Cancer. It also aims to explore the feasibility of using a novel universal CAR-T cell platform. Phase: EARLY_PHASE1 Status: SUSPENDED Conditions: HCC - Hepatocellular Carcinoma; NSCLC (Advanced Non-small Cell Lung Cancer) Interventions: Universal CAR-T cells injection for treating HCC and NSCLC; MMF Immunosuppression

Keywords

Sources